
Results
3
Companies which are more than 50% undervalued based on analyst price target.
3 companies
Zealand Pharma
Market Cap: DKK 19.8b
A biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.
ZEAL
DKK 289.30
7D
1.2%
1Y
-20.7%
ChemoMetec
Market Cap: DKK 6.4b
Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.
CHEMM
DKK 361.60
7D
-2.5%
1Y
-35.7%
BioPorto
Market Cap: DKK 544.6m
An in-vitro diagnostics company, focuses on developing biomarker tests to help clinicians detect the kidney injury in critically ill patients at earlier stage in Denmark, rest of Europe, North America, and Asia.
BIOPOR
DKK 1.12
7D
-0.4%
1Y
-19.8%